{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:53:29Z","timestamp":1793109209557,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["21147"],"award-info":[{"award-number":["21147"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["30974"],"award-info":[{"award-number":["30974"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022720","name":"Fondazione Regionale per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["CP2_10\/2018"],"award-info":[{"award-number":["CP2_10\/2018"]}],"id":[{"id":"10.13039\/501100022720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CN3 - National Center for Gene Therapy and Drugs based on RNA Technology"],"award-info":[{"award-number":["CN3 - National Center for Gene Therapy and Drugs based on RNA Technology"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Hub Life Science\u2013 Terapia Avanzata (LSH-TA) PNC-E3-2022-23683269"],"award-info":[{"award-number":["Hub Life Science\u2013 Terapia Avanzata (LSH-TA) PNC-E3-2022-23683269"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Research Project on CAR-T cells for hematological malignancies and solid tumors\", as part of the Alliance Against Cancer (ACC) network initiative-grant number: RCR-2023-23684268"],"award-info":[{"award-number":["Research Project on CAR-T cells for hematological malignancies and solid tumors\", as part of the Alliance Against Cancer (ACC) network initiative-grant number: RCR-2023-23684268"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06416-3","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:44:58Z","timestamp":1747647898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability"],"prefix":"10.1186","volume":"23","author":[{"given":"Ilaria","family":"Pisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Melita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Borges","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Savino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cuofano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pedrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cesana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Cabiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Quaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gaimari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Tazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bocchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Dastoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-5946","authenticated-orcid":false,"given":"Giuseppe","family":"Gaipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Introna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Golay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7327-418X","authenticated-orcid":false,"given":"Sarah","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"6416_CR1","doi-asserted-by":"crossref","unstructured":"Magnani CF, Tettamanti S, Alberti G, Pisani I, Biondi A, Serafini M et al. Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? Cells. 2020 May 27 [cited 2021 Dec 13];9(6). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32471151\/","DOI":"10.3390\/cells9061337"},{"key":"6416_CR2","doi-asserted-by":"crossref","unstructured":"Magnani CF, Mezzanotte C, Cappuzzello C, Bardini M, Tettamanti S, Fazio G et al. Preclinical efficacy and safety of CD19CAR Cytokine-Induced killer cells transfected with sleeping beauty transposon for the treatment of acute lymphoblastic leukemia. Hum Gene Ther. 2018;29(5).","DOI":"10.1089\/hum.2017.207"},{"key":"6416_CR3","doi-asserted-by":"crossref","unstructured":"Rotiroti MC, Buracchi C, Arcangeli S, Galimberti S, Valsecchi MG, Perriello VM et al. Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System. Mol Ther. 2020 Sep 2 [cited 2021 Apr 1];28(9):1974\u201386. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32526203\/","DOI":"10.1016\/j.ymthe.2020.05.021"},{"issue":"12","key":"6416_CR4","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1182\/bloodadvances.2022008762","volume":"7","author":"VM Perriello","year":"2023","unstructured":"Perriello VM, Rotiroti MC, Pisani I, Galimberti S, Alberti G, Pianigiani G, et al. IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML. Blood Adv. 2023;7(12):2855\u201371.","journal-title":"Blood Adv"},{"key":"6416_CR5","doi-asserted-by":"crossref","unstructured":"Turazzi N, Fazio G, Rossi V, Rolink A, Cazzaniga G, Biondi A et al. Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia. Vol. 182, British journal of haematology. England; 2018. pp. 939\u201343.","DOI":"10.1111\/bjh.14899"},{"issue":"11","key":"6416_CR6","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1172\/JCI138473","volume":"130","author":"CF Magnani","year":"2020","unstructured":"Magnani CF, Gaipa G, Lussana F, Belotti D, Gritti G, Napolitano S, et al. Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities. J Clin Invest. 2020;130(11):6021\u201333.","journal-title":"J Clin Invest"},{"key":"6416_CR7","doi-asserted-by":"publisher","first-page":"876339","DOI":"10.3389\/fimmu.2022.876339","volume":"13","author":"N Watanabe","year":"2022","unstructured":"Watanabe N, Mo F, McKenna MK. Impact of manufacturing procedures on CAR T cell functionality. Front Immunol. 2022;13:876339.","journal-title":"Front Immunol"},{"issue":"3","key":"6416_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jcyt.2021.11.004","volume":"24","author":"E Gotti","year":"2022","unstructured":"Gotti E, Tettamanti S, Zaninelli S, Cuofano C, Cattaneo I, Rotiroti MC, et al. Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use. Cytotherapy. 2022;24(3):334\u201343.","journal-title":"Cytotherapy"},{"key":"6416_CR9","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.1038\/mtm.2014.15","volume":"1","author":"P Bajgain","year":"2014","unstructured":"Bajgain P, Mucharla R, Wilson J, Welch D, Anurathapan U, Liang B, et al. Optimizing the production of suspension cells using the G-Rex M series. Mol Ther Methods Clin Dev. 2014;1:14015.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"6416_CR10","doi-asserted-by":"publisher","first-page":"e1057386","DOI":"10.1080\/2162402X.2015.1057386","volume":"5","author":"M-A Forget","year":"2016","unstructured":"Forget M-A, Haymaker C, Dennison JB, Toth C, Maiti S, Fulbright OJ, et al. The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity. Oncoimmunology. 2016;5(2):e1057386.","journal-title":"Oncoimmunology"},{"issue":"4","key":"6416_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3324\/haematol.2012.076430","volume":"98","author":"R Chakraborty","year":"2013","unstructured":"Chakraborty R, Mahendravada A, Perna SK, Rooney CM, Heslop HE, Vera JF, et al. Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease. Haematologica. 2013;98(4):533\u20137.","journal-title":"Haematologica"},{"issue":"3","key":"6416_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jcyt.2017.12.014","volume":"20","author":"L Xiao","year":"2018","unstructured":"Xiao L, Chen C, Li Z, Zhu S, Tay JC, Zhang X, et al. Large-scale expansion of V\u03b39V\u03b42 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells. Cytotherapy. 2018;20(3):420\u201335.","journal-title":"Cytotherapy"},{"key":"6416_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-0716-0146-4_12","volume":"2086","author":"J Ludwig","year":"2020","unstructured":"Ludwig J, Hirschel M. Methods and process optimization for Large-Scale CAR T expansion using the G-Rex cell culture platform. Methods Mol Biol. 2020;2086:165\u201377.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"6416_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1128\/jvi.69.2.748-755.1995","volume":"69","author":"PM Challita","year":"1995","unstructured":"Challita PM, Skelton D, el-Khoueiry A, Yu XJ, Weinberg K, Kohn DB. Multiple modifications in Cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol. 1995;69(2):748\u201355.","journal-title":"J Virol"},{"issue":"4","key":"6416_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0092-8674(00)80436-5","volume":"91","author":"Z Ivics","year":"1997","unstructured":"Ivics Z, Hackett PB, Plasterk RH, Izsv\u00e1k Z. Molecular reconstruction of sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell. 1997;91(4):501\u201310.","journal-title":"Cell"},{"issue":"6","key":"6416_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ng.343","volume":"41","author":"L M\u00e1t\u00e9s","year":"2009","unstructured":"M\u00e1t\u00e9s L, Chuah MKL, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, et al. Molecular evolution of a novel hyperactive sleeping beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet. 2009;41(6):753\u201361.","journal-title":"Nat Genet"},{"key":"6416_CR17","doi-asserted-by":"crossref","unstructured":"CF M. G G, F L, D B, G G, S N, Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities. J Clin Invest. 2020 Nov 2 [cited 2021 Sep 15];130(11):6021\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32780725\/","DOI":"10.1172\/JCI138473"},{"key":"6416_CR18","doi-asserted-by":"crossref","unstructured":"Deng Q, Han G, Puebla-Osorio N, Ma MCJ, Strati P, Chasen B et al. Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nat Med. 2020 Dec 1 [cited 2022 Aug 6];26(12):1878\u201387. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33020644\/","DOI":"10.1038\/s41591-020-1061-7"},{"key":"6416_CR19","doi-asserted-by":"crossref","unstructured":"Fraietta JA, Lacey SF, Orlando EJ, Pruteanu-Malinici I, Gohil M, Lundh S et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med. 2018 May 1 [cited 2022 Aug 6];24(5):563\u201371. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29713085\/","DOI":"10.1038\/s41591-018-0010-1"},{"issue":"1","key":"6416_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJW van der Windt","year":"2012","unstructured":"van der Windt GJW, Everts B, Chang C-H, Curtis JD, Freitas TC, Amiel E, et al. Mitochondrial respiratory capacity is a critical regulator of CD8\u2009+\u2009T cell memory development. Immunity. 2012;36(1):68\u201378.","journal-title":"Immunity"},{"issue":"4","key":"6416_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38(4):633\u201343.","journal-title":"Immunity"},{"key":"6416_CR22","doi-asserted-by":"crossref","unstructured":"Zhao Y, Chen J, Andreatta M, Feng B, Xie Y-Q, Wenes M et al. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol.2024 Nov;42(11):1693-1704","DOI":"10.1038\/s41587-023-02060-8"},{"key":"6416_CR23","unstructured":"Magnani CF, Turazzi N, Benedicenti F, Calabria A, Tenderini E, Tettamanti S, et al.Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform. Oncotarget. 2014; Available from: http:\/\/www.oncotarget.com\/abstract\/9955."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06416-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06416-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06416-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:45:21Z","timestamp":1747647921000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06416-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6416"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06416-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The in vivo studies were approved by the Italian Ministry of Health. Procedures involving animals were conformed with protocols approved by the Milano-Bicocca University in compliance with national and international law and policies. All in vivo experiments were conducted at the University of Milano-Bicocca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"559"}}